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Background: Modern medicine often clashes with traditional medicine such as Chinese herbal medicine because
of the little understanding of the underlying mechanisms of action of the herbs. In an effort to promote integration
of both sides and to accelerate the drug discovery from herbal medicines, an efficient systems pharmacology
platform that represents ideal information convergence of pharmacochemistry, ADME properties, drug-likeness, drug
targets, associated diseases and interaction networks, are urgently needed.
Description: The traditional Chinese medicine systems pharmacology database and analysis platform (TCMSP) was
built based on the framework of systems pharmacology for herbal medicines. It consists of all the 499 Chinese
herbs registered in the Chinese pharmacopoeia with 29,384 ingredients, 3,311 targets and 837 associated diseases.
Twelve important ADME-related properties like human oral bioavailability, half-life, drug-likeness, Caco-2 permeability,
blood-brain barrier and Lipinski’s rule of five are provided for drug screening and evaluation. TCMSP also provides
drug targets and diseases of each active compound, which can automatically establish the compound-target and
target-disease networks that let users view and analyze the drug action mechanisms. It is designed to fuel the
development of herbal medicines and to promote integration of modern medicine and traditional medicine for
drug discovery and development.
Conclusions: The particular strengths of TCMSP are the composition of the large number of herbal entries, and
the ability to identify drug-target networks and drug-disease networks, which will help revealing the mechanisms
of action of Chinese herbs, uncovering the nature of TCM theory and developing new herb-oriented drugs. TCMSP
is freely available at http://sm.nwsuaf.edu.cn/lsp/tcmsp.php.
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Traditional herbal medicine with the longest history in
Asia, is a cost-effective system of medical practice that
differs in substance, methodology, and philosophy from
modern medicine, and plays an important role in health
maintenance for the peoples of the world [1]. The increas-
ing popularity of herbal products has seen the monetary
value of the industry increase to hundreds of millions of
dollars per annum, concomitantly, there is increasing
interests and need to dissect and evaluate the complex
physiological effects of herbal products rigorously.* Correspondence: yh_wang@nwsuaf.edu.cn
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unless otherwise stated.Herbal medicines formula often combines different
botanicals, sometimes containing even up to 50 species
and thousands of chemical compounds. However, only
a part of them exhibit favorable pharmacokinetics (the ab-
sorption, distribution, metabolism, and excretion (ADME)
properties of a drug) with potential of a biological effect
[2]. Moreover, the therapeutic effects of these herbal
products might arise from cooperate actions of the
herbal ingredients. All these resist the conventional ana-
lytical chemistry and pharmacology technologies which
intend to isolate and identify chemical constituents pos-
sessing possible pharmacological effects.
Corresponding to the complexity of the components
in diverse herbs or even in one herb, herbal medicines
hit multiple biological targets involved in various patho-
genesis. Clearly, in a systems level to search potentialtd. This is an Open Access article distributed under the terms of the Creative
commons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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(computational method) should be the first choice,
owing to the shortages of the ‘wet’ experiment as time-
consuming, expensive and also being limited in small
scale [3]. Alternatively, a comprehensive systems-based
approach, which could simultaneously prioritize all the
active ingredients and their targets in the crude drugs, is
necessary.
More importantly, multi-component and multi-function
features in herbal concoctions make their pharmacological
and toxicological effects difficult to be evaluated inde-
pendently. It might be more suitable to view through the
lens of systems-based approaches. By considering drug
actions and side effects in the context of the regulatory
networks within which the drug targets and disease gene
products function, systems analysis promises to greatly
increase our knowledge of the mechanisms underlying the
multiple actions of drugs. Thus, the application of systems
pharmacology to herbal medicine affords new possibilities
for investigating the explicit targets of medicinal herbs’
active ingredients and their interactions in the context of
molecular networks [4-7].
In our previous work, we have proposed a novel inte-
grated herbal medicine systems pharmacology (HmSP)
platform for the purpose of investigating how herbs
interact with the human body from a molecular level to
the organism level [8]. This systems/network pharmacol-
ogy methodology has been successfully applied to dissect
basic TCM theories such as yin-yang theory [9], qi-blood
[5], herbal synergy [10,11], as well as to develop new drugs
[7]. However, systems pharmacology, as a novel holistic, a
multi-disciplinary, integrative field, is still difficult to be
widely applied. An accessible systems pharmacology plat-
form of Chinese herbal medicines that captures the rela-
tionships between drugs, targets and diseases is urgently
needed to help understand basic TCM theories, illustrate
the mechanisms of action and develop new drugs.
Presently, several databases have provided useful tools
in different aspects for TCM investigations. For example,
TCM-ID [12] and TCM Database@Taiwan [13] provide
the largest number of herbal ingredients with 3D struc-
tures and functional properties. Chem-TCM [14] and HIT
[15] focus on herbal compounds and their corresponding
targets. TCMID [16] comprises TCM formulae, herbs,
ingredients and the targets and diseases. CVDHD [17]
collects those natural products related to cardiovascular
diseases and targets. Comparisons among these data-
bases are listed on the TCMSP website.
Here, we constructed a unique systems pharmacology
platform of Chinese herbal medicines, which is different
from the above-mentioned databases. The newly devel-
oped TCMSP provides up-to-date, quantitative and sys-
tems information about TCM ingredients, ADME-related
properties, targets and diseases. TCMSP is unique in threekey ways: (1) Integration of a large scale structural data
(29,384 chemicals in total with 13,144 unique mole-
cules) with manually curated information for all registered
herbs in Chinese pharmacopoeia; (2) Incorporation of 12
key ADME-related properties from diverse sources for
active compound screening; (3) Establishment of the
compound-target, target-disease networks for deep
study of TCM theory, mechanisms of action and dis-
covery of new drugs. In total, TCMSP contains more
than 84260 compound-target pairs (CT pairs) and 2387
target-disease pairs (TD pairs).
In addition, the TCMSP website is more than a data
repository. It contains tools for visualization and ana-
lysis of TCM results on the network level. Such ap-
proach to systematic and multi-target drug discovery
could lead to a new generation of candidates with
improved physicochemical and pharmacokinetics prop-
erties. Unexpected associations can also be revealed
thereby furthering the understanding of the mecha-
nisms of diverse interactions and potentially indicating
novel treatments. Therefore, TCMSP is a powerful
knowledge repository and analysis platform for chem-
ists, biologists and pharmacologists.
Construction and content
Database scheme
TCMSP is divided into three major categories: (1) Com-
pounds, targets and diseases information (Figure 1 B1,
B2 and B3); (2) Herbal ingredients with their ADME-re-
lated properties (Figure 1 C1); (3) Compounds-Targets
relationships (Figure 1 C2) and Targets-Diseases rela-
tionships (Figure 1 C3).
Herbal ingredients
In order to gather all available information about ingre-
dients of herbal medicines, we performed an extensive
literature search for each herbal medicine. Structure files
of molecules were downloaded from PubChem [18]
Compound database, ChEMBL [19] and ChemSpider [20],
or produced by ISIS Draw 2.5 (MDL Information Systems,
Inc.) and further optimized by Sybyl 6.9 (Tripos, Inc.) with
Sybyl force field and default parameters [2,21]. Different
format types of the chemical files were converted to SDF
format by Open Babel [22]. The duplicates were removed
according to InChIKey.
ADME-related properties
To analyze the druggability of herbs on molecular level,
the database was structured to incorporate several import-
ant ADME-related properties such as human oral bioavail-
ability (OB) [23], half-life (HL) Yao Y, Wei Z, Yonghua W:
A novel Systems Pharmacology model for herbal medicine
injection: a case using Reduning Injection. submitted,
drug-likeness (DL) [4], FASA- [24], Caco-2 permeability
Figure 1 Database scheme and search flow chart. To obtain the Comprehensive Analysis Page (C) of a herb, users can search from (A) with
Herbal name; Searching by Chemical name, InChIKey or CAS number of a compound leads to Compound Information page (B1). Searching by
Target name to Target Information page (B2), Disease name to Disease Information page (B3), respectively; B1-B2-B3 are cross reference via
Herbs-Compounds-Targets-Diseases (H-C-T-D) references on each page, which will all lead to the Comprehensive Analysis Page eventually. C1 offers a
screening tool for compounds screening with diverse criteria. CTN and TDN could be downloaded in C2 and C3, respectively. Finally, users can save
and analyze the networks in Cytoscape software or other network analysis software (C4).
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five (MW, AlogP, TPSA, Hdon, Hacc) [25]. Detailed pa-
rameters’ information, screening criteria and calculation
can be obtained from TCMSP website (http://sm.nwsuaf.
edu.cn/lsp/load_intro.php?id=29).
Drug targeting and disease association
Target information was obtained from DrugBank data-
base [26]. Drug-Target mappings were obtained from
two sources. Experimental validated drug-target pairs
were retrieved from HIT database [15]. For those com-
pounds without validated targets, the SysDT model con-
structed in our previous work [27] was used to predict
the potential targets of a compound. SysDT shows im-
pressive performance of prediction for drug-target inter-
actions, with a concordance of 82.83%, a sensitivity of
81.33%, and a specificity of 93.62%, respectively. The dis-
ease information was obtained from TTD database [28]
and PharmGKB (https://www.pharmgkb.org/).
Network building and analysis
In order to analyze the CT and TD relationships, we have
developed a visualization interface by Cytoscape Web [29],
from which the network can be displayed within webpage
and downloaded as XGMML format. Further topologicalanalysis can be implemented with the NetworkAnalyzer
[30] plugin in Cytoscape software [31].
Website and server
TCMSP is freely available at: http://sm.nwsuaf.edu.cn/
lsp/tcmsp.php. It is designed as a relational database and
implemented in MySQL 5.1.63 with Apache 2.2.22 as




There are six major sections in TCMSP website (Home-
page, How to search, TCMSP User Guide, Browse,
Download and Parameter information). Users can
search herbal name, ingredient’s chemical name, InChI-
Key, CAS number, target name or disease name in the
search box at the TCMSP homepage. Querying princi-
ples and database structure are illustrated in Figure 1. A
movie tutorial on the “How to search” page gives users
a brief scope of TCMSP database. The “TCMSP User
Guide” page offers a detailed case study. From the
“Browse” page, users can browse all the herbal medi-
cines, herbal ingredients, targets and diseases. “Parame-
ters information” page introduces each ADME-related
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TCMSP can be freely downloaded at the “Download”
page.
Drug discovery and drug combination
ADME evaluations of drugs are critical procedures in drug
discovery and development [32]. Unfavorable pharma-
cokinetics properties were the primary causes of costly
late-stage failures in drug development [33]. To esti-
mate the possibility of converting a compound into a
drug, the TCMSP database incorporated a series of key
ADME-related properties including compound OB, DL,
FASA-, Caco-2 permeability, BBB, HL and Lipinski’s
rule of five. This database can easily screen out the mole-
cules which obey these rules or other customized thresh-
olds. For example, in our case study of Licorice, 69
bioactive compounds of licorice were obtained by ADME
screening with the criteria OB ≥ 40% and DL ≥ 0.18.
Investigate mechanisms of action of herbal medicines
and TCM formula
Understanding how the diverse chemical components in
medicinal herbs contribute to the overall pharmaco-
logical effect is a major challenge for current studies.
TCMSP provides information on the ability of herbs to
overcome biological barriers and their associated drug
targets. The key techniques in the TCMSP platform have
been successfully applied in the previous work to explore
the mechanisms of action of herbal medicines and TCM
formula in the treatment of cardiovascular diseases and
virus diseases [2,7,34,35]. For instance, with this model,
two representative herbs Lonicera japonica and Fructus
Forsythiae were analyzed regarding their pharmaco-
logical effect on influenza, inflammation and otherFigure 2 Workflow of the general TCMSP based research.diseases. Janus-function of these chemical compounds in
both herbs was uncovered: directly inhibiting virus repli-
cations and simultaneously promoting host immune re-
sponse [35]. With the help of TCMSP, researches could
uncover the mechanism of pharmacological action of
herbal medicines more comprehensively.
Uncover the nature of TCM theory
The selection of those compound formula, or fufang, is
based on the holistic philosophy of traditional Chinese
medicine and follows traditional TCM theory, including
the holistic philosophy, qi-enriching and blood-tonifying
natures or the rule of “Jun–Chen–Zuo–Shi”, known as the
Four Responsible Roles. However, the molecular basis of
these basic theory and the mechanisms of action are still
a mystery. Our previous research shows that systems
pharmacology-based study of TCM may open up the
possibility to understand the TCM theory in the context
of a molecular network. For example, we have applied
systems pharmacology to dissect the rule of drug com-
bination for TCM [36], which is exemplified by Ma
huang Decoction (also known as Ephedra Decoction,
MHD). For the first time, by this methodology, we have
revealed the chemical features of the qi-enriching and
blood-tonifying compounds, and have uncovered the
targets, leading to the deep understanding of the nature
of qi-blood theory [5].
Case study
Licorice is one of the oldest and most popular herbal med-
icines in the world. It has been broadly used in traditional
Chinese medicine as a cough reliever, anti-inflammatory,
anti-anabrosis, immunomodulatory, anti-platelet, antiviral
(hepatitis) and detoxifying agent. However, due to its
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mechanisms of action, deep understanding of licorice is
still difficult. This case will show us how to use TCMSP
for screening active ingredients, identifying drug targets
and diseases. Here we will introduce the process and
results of this study briefly (Figure 2), detailed infor-
mation about the biological basis of pharmacology of
licorice can be reached at our previous work [6].
We retrieved 280 known licorice compounds from
TCMSP. The ADME screening was applied with the criteria
OB ≥ 40% and DL ≥ 0.18. Under these criteria, 69 ingredi-
ents in licorice are identified as active substances. These
compounds are then mapped to the Compound-Target net-
work and Target-Disease network. The networks can be
downloaded as a XGMML file from TCMSP, or imported
into Cytoscape software and analyzed with the NetworkA-
nalyzer plugin. We calculated two key topological parame-
ters, degree and betweenness, to specify the importance of a
node (a compound or a target) and how this node influences
the communication between two nodes.
Finally, we obtained 91 targets related with different dis-
eases, which are critical for understanding the pharmaco-
logical mechanisms of licorice. The generated drug–target
network suggests that glyasperins C, licoagrocarpin, gly-
cyrrhizic acid and the target proteins PTPN1, HRH1, F2
with high degree or betweenness are the key components
playing important roles in the drug–target interactions.
For instance, compounds liquiritin and licochalcone G can
destroy bacteria by targeting the metalloelastase and
strengthen the tissue macrophages to defense against ex-
ternal invasions. Additionally, details of utilizing systems
pharmacology methods in TCM can be referred to our
previous work [8].
Conclusion
The particular strengths of TCMSP are the composition of
the large number of herbal entries with ADME properties,
and the ability to identify drug-target networks and drug-
disease networks, which will reveal the mechanisms of ac-
tion of Chinese herbs, uncover nature of TCM theory and
develop new herbal-oriented drugs. In the future version,
more medicinal and pharmacological data will be added,
such as the drug action mode: stimulation and inhibition,
drug combination for various diseases etc. Particularly,
we are planning to implement the physiologically based
pharmacokinetics (PBPK) method to provide a more
realistic description of the behavior of the substance in
various tissues and organs.
Availability and requirements
TCMSP is freely accessible at http://sm.nwsuaf.edu.cn/
lsp/tcmsp.php. The database is made available under the
Open Database License: http://opendatacommons.org/
licenses/odbl/1.0/. It will be updated monthly.Abbreviations
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